Total Pageviews

Thursday, September 17, 2026

HIV+ 01032000: PURPOSE 365...

HIV+ 01032000: PURPOSE 365...:   PURPOSE 365  is a part of a PrEP study by Gilead .  Currently, lenacapavir under the name Yetzugo is being marketed as a twice yearly P...

No comments:

Post a Comment